University of Minnesota Medical School

Minneapolis, Minnesota 55455-0341

8 studies enrolling now · 43 studies all time

What they study most

Acid Maltase Deficiency, Acquired Non-accommodative Esotropia, Acquired Partially Accommodative Esotropia, Acute Alcoholic Hepatitis, Acute Coronary Syndrome, Acute Liver Failure, Acute Liver Injury, Drug Induced, Acute on Chronic Liver Failure (ACLF), Advanced Solid Tumor, Alcoholic Hepatitis, Alopecia, Alopecia Areata

Studies at this site

• Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC) — Recruiting now
• Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction — Recruiting now
• A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata — Recruiting now
• Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) — Recruiting now
• Immune Modulation During Palynziq® Treatment in Adults (IMPALA) — Recruiting now
• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease — Recruiting now
• FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors — Recruiting now
• Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis — Running, not enrolling
• HEALEY ALS Platform Trial - Master Protocol — Running, not enrolling
• Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 — Running, not enrolling
• Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx — Completed
• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata — Completed
• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial — Completed
• Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens — Completed
• A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment — Completed
• A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes — Completed
• Deep Brain Stimulation for Major Depressive Disorder — Stopped early
• JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF — Completed
• Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease — Completed
• Drug Treatment for Pathologic Gambling Disorder — Completed
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed
• Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early
• A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer — Completed
• Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003 — Stopped early
• Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) — Completed
• Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy — Completed
• A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes — Completed
• Clinical Performance Evaluation of DxN HBV Assay — Stopped early
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors — Completed
• Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Tobacco Treatment Medical Education in 10 Medical Schools — Completed
• T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum — Status unconfirmed
• Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy — Status unconfirmed
• An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia — Completed
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma — Completed
• Pesticides--Health Fertility and Reproductive Risk — Completed
• Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome) — Completed